Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 9/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 9/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 9/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | KCNQ3 | O43525 | 2/20 | 0.36 |
| ▸ | KCNQ2 | O43526 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GPR88 | Q9GZN0 | 1/20 | 0.36 |
| ▸ | LTB4R2 | Q9NPC1 | 2/20 | 0.35 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.34 |
| ▸ | STAT3 | P40763 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6737598 | 0.76 | SLC6A2 (0.45) | ATMSLC6A2SLC6A4KCNQ3KCNQ2 | |
| SCHEMBL6733188 | 0.75 | ALDH1A1 (0.40) | CHRM2CHRM1CHRM3ATMSLC6A2 | |
| SCHEMBL5718068 | 0.73 | ATM (0.40) | ATMSLC6A2SLC6A4KCNQ3KCNQ2 | |
| SCHEMBL6737836 | 0.72 | PREP (0.39) | CHRM2CHRM1CHRM3ATMSLC6A2 | |
| SCHEMBL5718155 | 0.72 | ALDH1A1 (0.42) | CHRM2CHRM1CHRM3ATMALDH1A1 | |
| SCHEMBL6738399 | 0.70 | SLC6A2 (0.39) | SLC6A2SLC6A4KCNQ3KCNQ2ALDH1A1 | |
| SCHEMBL6733197 | 0.70 | SLC6A2 (0.42) | CHRM2CHRM1CHRM3SLC6A2SLC6A4 | |
| SCHEMBL7161662 | 0.69 | SMN1; SMN2 (0.55) | ALDH1A1 | |
| SCHEMBL5718005 | 0.69 | SMN1; SMN2 (0.55) | ALDH1A1 | |
| SCHEMBL6844383 | 0.68 | KCNQ3 (0.49) | CHRM2CHRM1CHRM3SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040235830-A1 | Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases | BAYER AKTIENGESELLSCHAFT (DE) | 2004-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040235830-A1 | Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases | CYP46A1, REN, CYP11B2 | CHRM2 2522/4885CHRM1 2846/4885CHRM3 1844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.